REVERSE II trial decision rule helps identify women who can safely discontinue anticoagulants

(European Society of Cardiology) A clinical decision rule that can be applied to women after a first, unprovoked venous thromboembolism was able to identify those with a low-risk of recurrence who could safely discontinue anticoagulant therapy, researchers reported at ESC Congress 2016.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2bzbaFT